Novartis Investigative Site

Adelaide, South Australia

We've found

2 trials

at this facility

A Phase I Study of Oral ABL001 in Patients With CML or Ph+ ALL

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Adelaide,

Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Adelaide,

Use our guide to learn which trials are right for you!